Grace Therapeutics, Inc. ( GRCE) - Stock Earnings
GRCE Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 11, 2026, midnight | — / — | — | — / — | — |
GRCE Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -1.3 million USD | — USD |
| 2025Q4 | -3.2 million USD | — USD |
| 2026Q1 | -1.2 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
GRCE Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | -17.4 million USD | — USD |
| 2025 | -13.6 million USD | — USD |
| 2026 | -7.8 million USD | — USD |
| 2026 Est. | — | — |
GRCE
Price: $2.33
52 week price:
Earnings Per Share: -0.47 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 40.2 million